11th October 2009 - New research


Clinical Neuropharmacology [2009] 32 (4) : 189-192 (Hinson VK, Goetz CG, Leurgans S, Fan W, Nguyen T, Hsu A.) Complete abstract

IPX054, which is a form of L-dopa, in which there are two layers, has been shown to be slightly more effective than conventional forms of L-dopa, despite only having to be taken twice a day instead of throughout the day. L-dopa usually comes in two different formats : either the immediate release version, which satisfies the immediate need for L-dopa, or the controlled release version, which avoids the excessive effects of L-dopa by spreading out the effect over time. IPX054 combines the two types of L-dopa, immediate release and controlled release, in one tablet, in two different layers, aiming to provide the benefits of both formats. In clinical practice, this ease of administration may offer improved treatment compliance and effectiveness. For more current news go to Parkinson's Disease News.


E-MAIL NOTIFICATION : If you would like to be notified by e-mail when any new research, news reports, new books, or new resources are added to Parkinson's Disease News,  please double click on  E-MAIL NOTIFICATION, or e-mail [email protected].  No form of identity is required.  E-mail addresses are not used for any other purpose.

Parkinson's Disease News details all significant new research, news reports, new books, and new resources concerning Parkinson's Disease and those medical disorders that often coincide with Parkinson's Disease. It is compiled from an analysis of  all newly published research, news reports, new clinical trials, all newly published books, and new web sites. A summary and analysis of the new research are provided,  as well as links to the complete abstracts and news reports.





2006-2009  Viartis
2015-11-10 13:23:48
[email protected]